SynBioBeta 2026 Speaker

Gabriele Corso

Boltz

CEO

Gabriele received his PhD from MIT CSAIL where his research focused on developing novel ML frameworks to tackle challenging problems in drug discovery and he led the development of popular models in the space including DiffDock, Boltz-1 and Boltz-2.

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor splatter with lime dots
Blue watercolor splatter
var(--variable-xyeEn_rYM)

Reagan

Jarvis

Anocca AB

CEO, Co-founder

var(--variable-xyeEn_rYM)

Alex

Rives

CZI Biohub

Head of Science

var(--variable-xyeEn_rYM)

Karenโ€ฏ

Akinsanya

Schrodinger

President, R&D โ€“ Therapeutics

var(--variable-xyeEn_rYM)

Christopher

Arendt

Takeda

CSO, Head of Research

var(--variable-xyeEn_rYM)

Stef

van Grieken

Cradle

CEO

var(--variable-xyeEn_rYM)

Michael

Koeris

DARPA

Director, BTO

var(--variable-xyeEn_rYM)

Jennifer

Dionne

Pumpkinseed

CEO

var(--variable-xyeEn_rYM)

Daniyal

Hussain

GSK

Exec. Dir., Tech BD

var(--variable-xyeEn_rYM)

Cynthia

Hong

Novartis

Dir., Search & Evaluation

var(--variable-xyeEn_rYM)

Sarah Lynn

Tao

CSL Behring

Sr. Dir., S&E; Ig TA & Tech Lead

Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure
Blue watercolor illustration of a folded protein structure

SynBioBeta 2027 May 3-6, San Jose, California